Company news
Abbott Laboratories news in 2026
Abbott Laboratories's news releases, calls and decks from 2026, newest first.
New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test
April 17, 2026
Abbott Reports First-Quarter 2026 Results; Updates Guidance to Reflect Acquisition of Exact Sciences
April 16, 2026
Illinois Jury Awards Four Families $70 Million in Verdict Against Baby Formula Manufacturer
April 10, 2026
New survey finds most Americans believe chronic diseases are preventable, but only 1 in 4 feel confident in how to care for their health
April 9, 2026
Global Medical Nutrition Market to Reach USD 31.1 Billion by 2035, Driven by Preventive Healthcare Across North America, Europe & Asia-Pacific - Key Players Nestlé, Abbott, Danone & DSM Lead Innovation
March 31, 2026
Abbott expands access to Precision Oncology portfolio through integration with Flatiron's OncoEMR® platform
March 30, 2026
Global Fertility Test Kits Market Grows as At-Home Diagnostics Rise, Led by Abbott, Clearblue
March 27, 2026
Abbott hosts conference call for first-quarter earnings
March 26, 2026
John Stamos and Jodie Sweetin reunite for "The (Second) Talk" with Cologuard® tests, encouraging colon cancer screening
March 24, 2026
Abbott completes acquisition of Exact Sciences
March 23, 2026
Abbott acquisition of Exact Sciences set to close on March 23, 2026
March 20, 2026
Landmark study shows Libre technology helps people with Type 2 diabetes on basal insulin improve glucose management
March 12, 2026
Abbott and Real Madrid launch nationwide effort to build the next 'Abbott Dream Team'
March 11, 2026
Abbott Laboratories next‑generation CardioMEMS™ remote heart failure monitoring reader receives FDA approval to enhance patient experience and help detect disease progression
February 27, 2026
Point of Care Diagnostics Market Competitive Landscape Report 2025 Featuring Top 5 Players - Sysmex, Abbott Laboratories, Becton Dickinson and Co, Danaher, Quidel Diagnostics
February 24, 2026
Abbott declares 409th consecutive quarterly dividend
February 20, 2026
Late-breaking data presentations showcase the safety and efficacy of Abbott's ablation catheters to treat people with atrial fibrillation
February 6, 2026
Abbott Reports Fourth-Quarter and Full-Year 2025 Results; Issues 2026 Financial Outlook
January 22, 2026
Abbott receives CE Mark for the TactiFlex™ Duo Ablation Catheter to treat patients with abnormal heart rhythms
January 20, 2026
TorHoerman Law Announces $495 Million Jury Verdict in Case Involving Abbott Laboratories
January 16, 2026
Innovative Health Receives 50th FDA Clearance to Reprocess Medical Devices
January 13, 2026
Abbott's FreeStyle Libre 3 Plus Now Covered Across Canada
January 7, 2026
Abbott hosts conference call for fourth-quarter earnings
January 5, 2026
Abbott's new Libre Assist app feature tackles a top need for people living with diabetes: in-the-moment food decisions
January 5, 2026